Clinical Trial Update: Analysis of CMTM6 Expression in Patients With Acute Myeloid Leukemia

View source ↗

Summary

The completed clinical trial analyzes CMTM6 expression in adults with acute myeloid leukemia to evaluate its potential as a biomarker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University of Freiburg | Conditions: Acute Myeloid Leukemia, Adult | Status: COMPLETED